SMS Pharmaceuticals Limited (BOM:532815)

Market Cap	21.04B
Revenue (ttm)	8.14B
Net Income (ttm)	731.47M
Shares Out	n/a
EPS (ttm)	8.53
PE Ratio	28.77
Forward PE	n/a
Dividend	0.40 (0.17%)
Ex-Dividend Date	Sep 22, 2025

Volume	1,265
Average Volume	5,447
Open	236.60
Previous Close	231.95
Day's Range	232.70 - 236.60
52-Week Range	175.00 - 398.00
Beta	n/a
RSI	52.30
Earnings Date	Aug 6, 2025

About SMS Pharmaceuticals

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyde...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1987
• Employees: 1,197
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532815

Financial Performance

In 2024, SMS Pharmaceuticals's revenue was 7.83 billion, an increase of 10.36% compared to the previous year's 7.09 billion. Earnings were 691.36 million, an increase of 38.75%.